Treatment of recalcitrant atopic dermatitis with omalizumab
- 1 January 2006
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 54 (1) , 68-72
- https://doi.org/10.1016/j.jaad.2005.09.030
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Failure of omalizumab for treatment of severe adult atopic dermatitisJournal of the American Academy of Dermatology, 2005
- Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEAllergy, 2004
- Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisAnnals of Allergy, Asthma & Immunology, 2004
- IgE-mediated Hypersensitivity Against Human Sweat Antigen in Patients with Atopic DermatitisActa Dermato-Venereologica, 2002
- A role for eosinophils in atopic dermatitisJournal of the American Academy of Dermatology, 2001
- IgE-mediated, Fc?RI-dependent allergen presentation: A pathogenetic factor in atopic dermatitis?Journal of the American Academy of Dermatology, 2001
- The High-Affinity Receptor for IgE Is the Predominant IgE-Binding Structure in Lesional Skin of Atopic Dermatitis PatientJournal of Investigative Dermatology, 1997
- Immunoglobulin E Response to Human Proteins in Atopic PatientsJournal of Investigative Dermatology, 1996
- Inhibition of Allergic Reactions with Antibodies to IgEInternational Archives of Allergy and Immunology, 1995
- The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitisClinical Immunology and Immunopathology, 1987